The recommendation about stocks Seattle Genetics Inc] is raise

Analysts of Goldman Sachs Group raised the recommendation about actions of companies Seattle Genetics Inc (NASDAQ: SGEN) to "to buy" with "to keep" in the analytical note extended among clients on Friday. Experts established the target price on this paper in $100 instead of former $78. Current rate - $77,1...